Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00551902Phase 1Withdrawn

Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes

Role: collaborator

NCT00347789Completed

Effectiveness of a Procedure for Previously Failed Glaucoma Surgery

Role: lead

NCT00347893Unknown

The Efficacy of Selective Laser Trabeculoplasty

Role: lead

All 3 trials loaded